Product Details
Synonyms
leukosialin, sialophorin, GPL115, Galactoglycoprotein, GALGP, Leukocyte sialoglycoprotein
Source
Human CD43, His Tag (CD3-H52H9) is expressed from human 293 cells (HEK293). It contains AA Ser 20 - Arg 253 (Accession # P16150-1 ).
Predicted N-terminus: Ser 20
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 25.3 kDa. The protein migrates as 45-80 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Human CD43, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
SEC-MALS

The purity of Human CD43, His Tag (Cat. No. CD3-H52H9) is more than 90% and the molecular weight of this protein is around 38-48 kDa verified by SEC-MALS.
Report
Bioactivity-SPR

Human Siglec-1, His Tag (Cat. No. SG1-H52H3) immobilized on CM5 Chip can bind Human CD43, His Tag (Cat. No. CD3-H52H9) with an affinity constant of 76.1 μM as determined in a SPR assay (Biacore 8K) (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Leukosialin
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
0 Details
- Highest Development Stage:
Preclinical
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















